Summit Therapeutics Inc. (SMMT)
NASDAQ·Healthcare·Biotechnology
$13.90
+6.29%
Mkt Cap $10.41B
Analyst Ratings
Buy
5
Hold
4
Sell
0
Price Target (20 analysts)
$19.50
Range $16.00 – $23.00
Implied Upside
+40.3%
Consensus $19.50 vs current $13.90
NASDAQ·Healthcare·Biotechnology
$13.90
+6.29%
Mkt Cap $10.41B
Buy
5
Hold
4
Sell
0
Price Target (20 analysts)
$19.50
Range $16.00 – $23.00
+40.3%
Consensus $19.50 vs current $13.90